Hemophilia of Georgia logo

Hemophilia of Georgia's Research Funding Impact

Hemophilia of Georgia provides funding to advance medical care and find a cure for people living with bleeding disorders.

HoG has provided over $8 million to help develop a cure for hemophilia and has funded grants totaling $1.25 million to develop the next generation of scientists in the field of bleeding disorders.

❤️ Make an impact today!

Choose an amount to donate One-time
Choose an amount
Hemophilia of Georgia is a 501(c)3 tax-exempt organization, and your donation is tax deductible within the guidelines of U.S. law. Please keep your receipt as your official record. We'll email it to you upon successful completion of your donation.

Research to date

Since 2012, HoG has funded gene therapy research at two institutions: The Aflac Cancer and Blood Disorders Center at Emory University, Atlanta and St. Jude Children’s Research Hospital in Memphis, Tennessee. Our contributions of over $8 million are to develop a cure for hemophilia (factor VIII, factor IX, and factor VII deficiencies).

Hemophilia of Georgia (HoG) has a long-standing commitment to providing critical funding to help build a strong research community for the bleeding disorder population. In fiscal year 2024, we provided $165,000 for Hemophilia Clinical Scientist Development Grants.

Frequently asked questions